Nursing Experience With Patients Receiving Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab For Waldenstrom'S Macroglobulinemia: Five Years Of Follow-Up From The Phase 3 Innovate (Tm) Study
ONCOLOGY NURSING FORUM（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要